Amedica (NSDQ:AMDA) said today that it priced a stock offering worth $11 million for the silicon nitride implants it makes.
Salt Lake City, Utah-based Amedica said it plans to float more than 3.6 million shares of common stock at $1 apiece, plus nearly 7,400 preferred shares at $1,000 each, and 11 million warrants.
The common stock shares include a 5-year warrant, also priced at $1, while the preferred shares consist of 1,000 convertible shares and 1,000 warrants, the company said.
Amedica, which makes spinal implants, is also developing implants for hip and knee arthroplasty and for dental applications. The company said it expects to close the offering July 8. The flotation includes a 45-day underwriters option for another 1.65 million shares and the same number of warrants.
Ladenburg Thalmann (NYSE:LTS) and Maxim Group are joint book-runners on the offering, Amedica said.
